Search Results 1591-1600 of 19448 for hemoglobin

1. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100 x 10^9 cells/L;; Absolute neutrophil count ≥ 1.5 x 10^9 cells/L). Adequate cardiac function: Left ventricular ...

2. Vitamin E Supplements Not Recommended for Those with Diabetes - Mayo Clinic News Network

   May 7, 2010 Dear Mayo Clinic: I have heard that vitamin E can be harmful to diabetics with heart problems. Can you tell me more about this?

3. Low White Blood Cell Count Not Always a Sign of Medical Problem - Mayo Clinic News Network

   February 4, 2011. Dear Mayo Clinic: I was told after my recent physical that my white blood cell count was low. Is this something to be concerned about?

4. Pharmacokinetic and Safety Study of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects with Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dL. Subject has the following blood chemistry levels at screening (obtained ≤ 14 days prior to starting Cycle 1 Day 1):. AST (SGOT) ...

5. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer - Mayo Clinic

   ... hemoglobin ≥ 10 g/dL, GFR ≥ 50 mL/min, may not have NYHA Class III heart failure;; Eligible for pembrolizumab (Dose-escalation cohorts, Cohorts A, B, G and ...

6. Synergy with Grid Therapy and Immune Checkpoint Inhibitors in Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN or direct bilirubin ...

7. How preeclampsia accelerates aging in women - Mayo Clinic News Network

   Dr. Vesna Garovic has shown that women with preeclampsia undergo a state of accelerated aging that propels them down the path of developing age-related ...

8. Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy Of BTX-9341 In Advanced And/​or Metastatic Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL. Note: Packed red blood cell transfusion is allowed up to 14 days prior to trial entry. Acceptable liver function. Bilirubin ≤ 2.0 ...

9. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

   - Hemoglobin ≥ 9 g/dL - Hepatic: - Total bilirubin < 2 x the institutional upper limit of normal (ULN). For participants with known Gilbert's Syndrome ≤ 3 ...

10. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

    Hemoglobin: <10 g/dL,; Aspartate aminotransferase (AST) >2.0 × upper limit of normal (ULN),; Alanine aminotransferase (ALT) >2.0 × ULN,; Total bilirubin >1.5 ...